Medicinal chemistry – Page 47
-
OpinionHow does being a chemist change your view on the world?
Scientific knowledge and analysis shape our view, but can also be selectively ignored
-
PodcastNepetalactone
The catnip compound that felines go crazy for could have exciting uses for humans, too, as Kat Arney finds out
-
-
FeatureAntidepressant pollution
What are the consequences of medicating wildlife against anxiety and depression? Ida Emilie Steinmark reports
-
FeatureHow ketamine could help treat severe depression
Nina Notman looks at how the party drug ketamine may hold the key to treating patients with severe depression
-
ResearchPutting the ‘ant’ in antibiotics
Antibacterial polyketides uncovered in the most unusual of places
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
NewsEuropean science groups voice concern over recent US policies
Leaders in Europe are being warned about the potential impacts of President Trump’s policies on research and innovation
-
-
News€1 million prize awarded for quick test to cut antibiotic use
Diagnostic device could help fight antimicrobial resistance by determining whether or not an infection is caused by bacteria
-
ResearchAutomated fluorine radiolabelling moves closer to the clinic
New technique could improve tumour diagnosis and treatment
-
ResearchMolecular structure is teixobactin’s pièce de résistance
Study builds scientists’ arsenal against drug-resistant superbugs
-
NewsAlzheimer’s disease: have drug developers been on the wrong track?
Dementia drug developers urged to look beyond amyloid
-
PodcastAdamantane
Brian Clegg introduces a crystalline hydrocarbon that isn’t as tough as it sounds, but is the basis of a wide range of medicines
-
ResearchCrystal structure lifts lid on LSD’s secrets
Structure of hallucinogen bound to a human serotonin receptor could explain LSD’s potent and long-lasting effects
-
NewsVaccine coalition to target emerging infectious diseases
Fund attempting to raise $1 billion to develop vaccines before an epidemic strikes
-
-
ResearchPersonalised medicine boost as cancer drug monitored in real-time
Aptamer-based sensors can track levels of small molecules in rats as the go about their business
-
-
BusinessTaming vaccines with chemistry
Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules